Developer docs
API playgroundTry for free, no card

Search company profiles

MycoDAO

Full company profile

uuid000f553

Namestring
MycoDAO
Websiteurl
mycodao.com
Company typeenum
Private
Founded yearint
2025
Descriptiontext

MycoDAO is a mycology-focused decentralized autonomous organization (BioDAO) that connects researchers, citizen scientists, laboratories, funders, and biotech builders through token-based community governance. The organization is structured as a non-profit DAO using the MYCO governance token and the Realms governance platform to allocate decentralized funding and make collective decisions about research priorities, rather than operating through traditional equity or institutional hierarchies.

The product ecosystem consists of five integrated components: LAB-IN-A-BOX modular laboratory facilities providing DNA sequencing, tissue storage, microscopy, biobanking, and automated research equipment; FungIP, a platform for managing and tokenizing fungal intellectual property; BLOCKS, a content and market intelligence platform covering bio funding and mycology research; the MYCO governance token distributed via the bio.xyz launchpad; and the underlying DAO governance framework itself. Underlying technology combines hardware (field sensors, lab equipment, environmental monitoring), software, AI tools and autonomous agents, bioinformatics, and data platforms into a decentralized scientific infrastructure designed to span the full pipeline from field discovery to commercial biotech application.

The business model is multi-stream and still early-stage. Described revenue streams include tokenized IP and licensing (FungIP), decentralized funding and grants managed through DAO governance, fee-for-service laboratory capabilities (DNA sequencing, microscopy, tissue storage), and recurring biobanking subscriptions. GTM is community-led, relying primarily on Discord engagement, open governance proposals, and content marketing rather than direct sales. Target customer segments span four primary personas: individual researchers and citizen scientists, science funders and investors, laboratories and research institutions, and biotech entrepreneurs building applications in medicine, agriculture, materials, fungal computing, and ecological restoration.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersChula Vista, United States
HQ citystring
Chula Vista
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
decentralized science, mycology research, biobanking services, DAO governance, DNA sequencing
Industry3 codes
PRIMARYHLAAAIAD
Synthetic Biology & Genetic Circuit Design Platforms (pathway engineering, chassis development)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
SECONDARYAFAJAHAE
Mycoprotein & Fungal Proteins (Fusarium/Mycelium-Based)
Agriculture & Food Production/Food Ingredients & Additives/Proteins & Protein Ingredients (Plant/Animal Proteins, Protein Isolates/Concentrates)
SECONDARYHLAGAEAI
Sample Logistics, Biorepository & IVD Kit Management (Trial Support)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
NAICS code3 codes
  • Medical and Diagnostic Laboratories6215
  • Business Associations813910
  • Blood and Organ Banks621991
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Membership Organizations8600
Product category
Decentralized Science Infrastructure
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Tokenized IP and Licensing
TypeLicensing Royalties
Description

Monetizing fungal intellectual property through tokenization, creating licensing models that generate revenue from discoveries while enabling community ownership.

mycodao.com
2Decentralized Funding and Grants
TypeSubscription Recurring
Description

Community-governed funding mechanisms that allocate capital to research projects, with grant distribution managed through DAO governance.

mycodao.com
3Laboratory Services
TypeTransaction Fee
Description

Fee-for-service laboratory capabilities including DNA sequencing, microscopy, tissue storage, and biobanking services for external researchers and partners.

mycodao.com
4Biobanking Services
TypeSubscription Recurring
Description

Specimen preservation and storage services for the scientific community, generating recurring revenue from maintained collections.

mycodao.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Operations, Technology or R&D, Infrastructure, Personnel
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 record
1FungIP
Description

Intellectual property initiative focused on fungal discoveries and licensing models

mycodao.com
Core offering1 text field

MycoDAO is a decentralized autonomous organization (BioDAO) focused on mycology that operates physical laboratory infrastructure (LAB-IN-A-BOX facilities), provides DNA sequencing, tissue storage, microscopy, and biobanking services, and channels community-governed decentralized funding and tokenized IP licensing toward fungal research and biotechnology development. It connects researchers, citizen scientists, labs, funders, and builders through software platforms including BLOCKS, FungIP, and the MYCO governance token.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

MycoDAO is a decentralized science platform organized as a BioDAO that bridges nature, funding, and scientific discovery in mycology. The ecosystem consists of MycoDAO as the core governance platform, the MYCO Token for community governance, BLOCKS as a market news and bio funding platform, FungIP for intellectual property management, and LAB-IN-A-BOX facilities providing physical laboratory infrastructure for DNA sequencing, tissue storage, microscopy, and biobanking. Together, these products create a pipeline connecting field discovery, lab infrastructure, AI tools, biological data, community funding, and commercialization.

Product and service1 record
1MycoDAO Platform
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
TypeDirect peer
Description

Molecule is a DeSci platform that tokenizes and funds biotech intellectual property through DAOs. It shares MycoDAO's exact model of using Web3 primitives to fund, govern, and license scientific IP — the closest analog in the DeSci ecosystem.

TypeDirect peer
Description

VitaDAO is a longevity-focused BioDAO that funds research through community-governed token treasuries and tokenizes resulting IP. Comparable to MycoDAO in structure (DAO governance, IP tokenization, lab infrastructure partnerships) but applied to longevity research.

TypeDirect peer
Description

LabDAO is a decentralized autonomous lab network connecting researchers with shared wet-lab infrastructure and tools. Directly comparable to MycoDAO's LAB-IN-A-BOX and biobanking offering; both target underfunded researchers with decentralized infrastructure.

TypeDirect peer
Description

AthenaDAO is a BioDAO funding women's health research through token-governed grants and IP tokenization. Comparable operating model and governance structure to MycoDAO, though focused on a different scientific vertical.

TypeOthers
Description

Bio.xyz is the DeSci launchpad through which MycoDAO distributes its MYCO token. It is an ecosystem infrastructure provider — enabling BioDAO creation — rather than a direct competitor, but serves as the closest platform-level peer.

TypeDirect peer
Description

MycoTechnology is a fungal fermentation company producing food ingredients from mycelium. Directly comparable to MycoDAO's biotech-builder vertical — particularly alternative protein and food applications — though it operates as a centralized CPG ingredient supplier.

TypeDirect peer
Description

Ecovative grows mycelium-based packaging, materials, and leather substitutes. Comparable on the materials and bioremediation verticals MycoDAO targets; operates as a centralized commercial supplier rather than a DAO.

TypeEmerging player
Description

Meati Foods produces whole-cut protein from mycelium. Comparable to MycoDAO's biotech-builder segment in alternative protein; operates a single-vertical commercial model rather than the multi-vertical DAO approach.

TypeBroad incumbent
Description

Ginkgo Bioworks is a publicly traded synthetic biology platform that programs cells for industrial applications. Comparable to MycoDAO's AI/bioinformatics and synthetic biology positioning, but operates at vastly larger scale and scope with a centralized business model.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

MycoDAO

Decentralized Science Infrastructuremycodao.com

What MycoDAO does

MycoDAO is a mycology-focused decentralized autonomous organization (BioDAO) that connects researchers, citizen scientists, laboratories, funders, and biotech builders through token-based community governance. The organization is structured as a non-profit DAO using the MYCO governance token and the Realms governance platform to allocate decentralized funding and make collective decisions about research priorities, rather than operating through traditional equity or institutional hierarchies.

The product ecosystem consists of five integrated components: LAB-IN-A-BOX modular laboratory facilities providing DNA sequencing, tissue storage, microscopy, biobanking, and automated research equipment; FungIP, a platform for managing and tokenizing fungal intellectual property; BLOCKS, a content and market intelligence platform covering bio funding and mycology research; the MYCO governance token distributed via the bio.xyz launchpad; and the underlying DAO governance framework itself. Underlying technology combines hardware (field sensors, lab equipment, environmental monitoring), software, AI tools and autonomous agents, bioinformatics, and data platforms into a decentralized scientific infrastructure designed to span the full pipeline from field discovery to commercial biotech application.

The business model is multi-stream and still early-stage. Described revenue streams include tokenized IP and licensing (FungIP), decentralized funding and grants managed through DAO governance, fee-for-service laboratory capabilities (DNA sequencing, microscopy, tissue storage), and recurring biobanking subscriptions. GTM is community-led, relying primarily on Discord engagement, open governance proposals, and content marketing rather than direct sales. Target customer segments span four primary personas: individual researchers and citizen scientists, science funders and investors, laboratories and research institutions, and biotech entrepreneurs building applications in medicine, agriculture, materials, fungal computing, and ecological restoration.

MycoDAO firmographics

Firmographics
Name
MycoDAO
Website
https://mycodao.com
Company type
Private
Founded year
2025
Operating status
Operating
Headcount range
1–10 employees
Ownership category
akta.pro rank

MycoDAO industry classification

Industry
Product category
Decentralized Science Infrastructure
NAICS
Medical and Diagnostic Laboratories (6215), Business Associations (813910), Blood and Organ Banks (621991)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Membership Organizations (8600)
akta.pro industry
PRIMARYHLAAAIAD
Synthetic Biology & Genetic Circuit Design Platforms (pathway engineering, chassis development)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
SECONDARYAFAJAHAE
Mycoprotein & Fungal Proteins (Fusarium/Mycelium-Based)
Agriculture & Food Production/Food Ingredients & Additives/Proteins & Protein Ingredients (Plant/Animal Proteins, Protein Isolates/Concentrates)
SECONDARYHLAGAEAI
Sample Logistics, Biorepository & IVD Kit Management (Trial Support)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)

Keywords

  • Decentralized science
  • Mycology research
  • Biobanking services
  • DAO governance
  • DNA sequencing

Where MycoDAO is headquartered

Location

Headquarters

HQ city
Chula Vista
HQ country
United States
HQ region
North America

Markets served

MycoDAO business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Operations, Technology or R&D, Infrastructure, Personnel

Revenue model

  1. Tokenized IP and Licensing: Monetizing fungal intellectual property through tokenization, creating licensing models that generate revenue from discoveries while enabling community ownership.
  2. Decentralized Funding and Grants: Community-governed funding mechanisms that allocate capital to research projects, with grant distribution managed through DAO governance.
  3. Laboratory Services: Fee-for-service laboratory capabilities including DNA sequencing, microscopy, tissue storage, and biobanking services for external researchers and partners.
  4. Biobanking Services: Specimen preservation and storage services for the scientific community, generating recurring revenue from maintained collections.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

MycoDAO product offering

Product offering

Core offering

MycoDAO is a decentralized autonomous organization (BioDAO) focused on mycology that operates physical laboratory infrastructure (LAB-IN-A-BOX facilities), provides DNA sequencing, tissue storage, microscopy, and biobanking services, and channels community-governed decentralized funding and tokenized IP licensing toward fungal research and biotechnology development. It connects researchers, citizen scientists, labs, funders, and builders through software platforms including BLOCKS, FungIP, and the MYCO governance token.

Product overview

MycoDAO is a decentralized science platform organized as a BioDAO that bridges nature, funding, and scientific discovery in mycology. The ecosystem consists of MycoDAO as the core governance platform, the MYCO Token for community governance, BLOCKS as a market news and bio funding platform, FungIP for intellectual property management, and LAB-IN-A-BOX facilities providing physical laboratory infrastructure for DNA sequencing, tissue storage, microscopy, and biobanking. Together, these products create a pipeline connecting field discovery, lab infrastructure, AI tools, biological data, community funding, and commercialization.

Differentiator

Problem solved

Functional benefit

Brands

  • FungIP: Intellectual property initiative focused on fungal discoveries and licensing models

Products and services

  • MycoDAO Platform

Companies that use MycoDAO

Customer profile

Segments4 records

Ideal customer profiles4 records

MycoDAO technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature7 records

MycoDAO partnerships and signals

Strategic signal

Recent moves6 records

Expansion highlights5 records

MycoDAO competitors and assessment

Company assessment

Broad incumbents

  • Perfect Day:
  • Ginkgo Bioworks: Ginkgo Bioworks is a publicly traded synthetic biology platform that programs cells for industrial applications. Comparable to MycoDAO's AI/bioinformatics and synthetic biology positioning, but operates at vastly larger scale and scope with a centralized business model.

Direct peers

  • Molecule: Molecule is a DeSci platform that tokenizes and funds biotech intellectual property through DAOs. It shares MycoDAO's exact model of using Web3 primitives to fund, govern, and license scientific IP — the closest analog in the DeSci ecosystem.
  • VitaDAO: VitaDAO is a longevity-focused BioDAO that funds research through community-governed token treasuries and tokenizes resulting IP. Comparable to MycoDAO in structure (DAO governance, IP tokenization, lab infrastructure partnerships) but applied to longevity research.
  • LabDAO: LabDAO is a decentralized autonomous lab network connecting researchers with shared wet-lab infrastructure and tools. Directly comparable to MycoDAO's LAB-IN-A-BOX and biobanking offering; both target underfunded researchers with decentralized infrastructure.
  • AthenaDAO: AthenaDAO is a BioDAO funding women's health research through token-governed grants and IP tokenization. Comparable operating model and governance structure to MycoDAO, though focused on a different scientific vertical.
  • MycoTechnology: MycoTechnology is a fungal fermentation company producing food ingredients from mycelium. Directly comparable to MycoDAO's biotech-builder vertical — particularly alternative protein and food applications — though it operates as a centralized CPG ingredient supplier.
  • Ecovative Design: Ecovative grows mycelium-based packaging, materials, and leather substitutes. Comparable on the materials and bioremediation verticals MycoDAO targets; operates as a centralized commercial supplier rather than a DAO.

Others

  • Bio.xyz: Bio.xyz is the DeSci launchpad through which MycoDAO distributes its MYCO token. It is an ecosystem infrastructure provider — enabling BioDAO creation — rather than a direct competitor, but serves as the closest platform-level peer.

Emerging players

  • Meati Foods: Meati Foods produces whole-cut protein from mycelium. Comparable to MycoDAO's biotech-builder segment in alternative protein; operates a single-vertical commercial model rather than the multi-vertical DAO approach.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

MycoDAO social profiles

Digital presence

MycoDAO financial estimates

Financial estimate

Revenue estimate

Valuation estimate

MycoDAO leadership team

Management profile

Number of profiles

MycoDAO funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

MycoDAO M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MycoDAO

What does MycoDAO do?

MycoDAO is a decentralized autonomous organization (BioDAO) focused on mycology that operates physical laboratory infrastructure (LAB-IN-A-BOX facilities), provides DNA sequencing, tissue storage, microscopy, and biobanking services, and channels community-governed decentralized funding and tokenized IP licensing toward fungal research and biotechnology development. It connects researchers, citizen scientists, labs, funders, and builders through software platforms including BLOCKS, FungIP, and the MYCO governance token.

Is MycoDAO a public or private company?

MycoDAO is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was MycoDAO founded?

MycoDAO was founded in 2025. It employs 1 to 10 people.

Where is MycoDAO based?

MycoDAO is headquartered in Chula Vista, United States, in the North America region.

How does MycoDAO make money?

Four revenue lines are on record. Tokenized IP and Licensing is the primary driver. The others are decentralized Funding and Grants, laboratory Services and biobanking Services.

Who are MycoDAO's main competitors?

Broad incumbents on record are Perfect Day and Ginkgo Bioworks. Direct peers are Molecule, VitaDAO, LabDAO, AthenaDAO, MycoTechnology and Ecovative Design. Bio.xyz is listed as an others. Meati Foods is listed as an emerging player.

Does MycoDAO have an API?

No public API is recorded for MycoDAO.

What industry is MycoDAO in?

MycoDAO's product category is Decentralized Science Infrastructure. Its primary akta.pro industry code is HLAAAIAD, Synthetic Biology & Genetic Circuit Design Platforms (pathway engineering, chassis development), with a secondary code of AFAJAHAE, Mycoprotein & Fungal Proteins (Fusarium/Mycelium-Based). Its NAICS code is 6215 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales